AR112111A1 - GPR6 RECEPTOR MODULATING TETRAHYDROPYRIDOPYRAZINES - Google Patents

GPR6 RECEPTOR MODULATING TETRAHYDROPYRIDOPYRAZINES

Info

Publication number
AR112111A1
AR112111A1 ARP180101695A ARP180101695A AR112111A1 AR 112111 A1 AR112111 A1 AR 112111A1 AR P180101695 A ARP180101695 A AR P180101695A AR P180101695 A ARP180101695 A AR P180101695A AR 112111 A1 AR112111 A1 AR 112111A1
Authority
AR
Argentina
Prior art keywords
tetrahydropyridopyrazines
receptor modulating
gpr6 receptor
gpr6
modulating
Prior art date
Application number
ARP180101695A
Other languages
Spanish (es)
Inventor
Todd Macklin
Huikai Sun
Kristin Schleicher
Holly Reichard
Holger Monenschein
Shota Kikuchi
Maria Hopkins
Stephen Hitchcock
Jason W Brown
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of AR112111A1 publication Critical patent/AR112111A1/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicación 1: Un compuesto caracterizado porque es de la fórmula (1), o una sal farmacéuticamente aceptable del mismo.Claim 1: A compound characterized in that it is of formula (1), or a pharmaceutically acceptable salt thereof.

ARP180101695A 2017-06-15 2018-06-15 GPR6 RECEPTOR MODULATING TETRAHYDROPYRIDOPYRAZINES AR112111A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762520430P 2017-06-15 2017-06-15

Publications (1)

Publication Number Publication Date
AR112111A1 true AR112111A1 (en) 2019-09-18

Family

ID=68069964

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101695A AR112111A1 (en) 2017-06-15 2018-06-15 GPR6 RECEPTOR MODULATING TETRAHYDROPYRIDOPYRAZINES

Country Status (1)

Country Link
AR (1) AR112111A1 (en)

Similar Documents

Publication Publication Date Title
AR108711A1 (en) FXR MODULATING COMPOUNDS (NR1H4)
CO2020014586A2 (en) Compounds
DOP2020000102A (en) HELPFUL COMPOUNDS TO INHIBIT CDK7
AR108768A2 (en) PIRIDINE AND PIRAZOL COMPOUNDS AND THEIR USES FOR HEMOGLOBIN MODULATION
AR101995A1 (en) INTEGRINA AVB6 ANTAGONIST COMPOUNDS
EA201891024A1 (en) TANK-BINDING KINASE INHIBITOR COMPOUNDS
AR103680A1 (en) BACE1 SELECTIVE INHIBITORS
EA201791304A1 (en) IZOHINOLINA DERIVATIVES FOR HIV TREATMENT
EA202193015A1 (en) CDK INHIBITORS
CO2018001383A2 (en) Derivatives of n- [pyridin-4-yl] methyl] -4 - {(1r) -1 - [(3s) -3-methyl-2,5-dioxopyrrolidin-3-yl] ethyl} benzamide as antagonists of the cgrp receptor "
EA201891644A1 (en) ANTIBACTERIAL CONNECTIONS AND THEIR APPLICATION
MD3395821T2 (en) Antitumoral compounds
EA201891342A1 (en) Isoindole compounds
AR105821A1 (en) USEFUL COMPOUNDS TO INHIBIT ROR-g-T
AR117920A1 (en) HUMAN IMMUNODEFICIENCY VIRUS REPLICATION INHIBITORS
EA201692368A1 (en) DERIVATIVES OBTAINED FROM HYALURONIC ACID AND CARNOSINE
MY193239A (en) Novel b-lactamase inhibitors
AR110770A1 (en) POTASSIUM CHANNEL MODULATORS
CL2017002651A1 (en) Aminohydrotiazine derivatives fused with tetrahydrofuran which are useful in the treatment of Alzheimer's disease
EA201990313A1 (en) DERIVATIVE TRIAZOLOPYRAZINONE USED AS A HUMAN PDE1 INHIBITOR
AR112111A1 (en) GPR6 RECEPTOR MODULATING TETRAHYDROPYRIDOPYRAZINES
EA201690908A1 (en) Pyrazolopyrmidine compounds
AR115865A2 (en) THERAPEUTIC COMPOUNDS
ECSP17000222A (en) NOVEL POLYMORPHIC FORM OF N- [2- (6-FLUORO-1H-INDOL-3-IL) ETHYL] -3- (2,2,3,3-TETRAFLUOROPROPOXI) BENZYLAMINE FOR THE TREATMENT OF ALZHÉIMER
RU2016108801A (en) Peptide with therapeutic effect against Alzheimer's disease